Association between metabolic syndrome, BMI, and serum vitamin D concentrations in rheumatoid arthritis
Identifieur interne : 001429 ( Main/Exploration ); précédent : 001428; suivant : 001430Association between metabolic syndrome, BMI, and serum vitamin D concentrations in rheumatoid arthritis
Auteurs : Ladan Goshayeshi [Iran] ; Hamidreza Saber [Iran] ; Maryam Sahebari [Iran] ; Zahra Rezaieyazdi [Iran] ; Houshang Rafatpanah [Iran] ; Habibollah Esmaily [Iran] ; Lena Goshayeshi [Iran]Source :
- Clinical Rheumatology [ 0770-3198 ] ; 2012-08-01.
English descriptors
Abstract
Abstract: Rheumatoid arthritis (RA) is the most common autoimmune arthritis. The impact of chronic inflammation on atherosclerosis and insulin resistance has been observed in several autoimmune diseases. On the other hand, metabolic syndrome (MetS); a cluster of traditional risk factors for atherosclerosis and diabetes seems to be prevalent in RA patients. It is reasonable to think that protective factors against inflammation can protect patients against atherosclerosis and diabetes, too. Vitamin D (Vit D), a novel immunomodulator, is recently considered to play a protective role against cardiovascular diseases, insulin resistance, and obesity. This cross-sectional study was designed to evaluate the impact of serum Vit D on MetS and body mass index (BMI). One hundred twenty RA patients were enrolled. MetS was assessed according to Adult Treatment Panel III criteria. All patients with known confounders influencing Vit D serum levels were excluded. Serum value of 25-hydroxyvitamin D (25(OH)D) was measured using a commercial ELISA kit. Data were analyzed by SPSS software. A logistic regression analysis stated that prednisolone dosage [p = 0.028, β = 0.177, odds ratio (OR) = 1.194, confidence interval (CI, 1.09–1.32)], age [p = 0.002, β = 0.146, OR = 1.57, CI (1.05–1.27)] and Vit D serum levels [p = 0.049, β = −3.766, OR = 0.023, CI (0.001–0.978)] are all significant predictors of MetS occurrence in RA patients. It was shown that 25(OH)D is a protective factor against MetS. It was also shown that there is a negative correlation between BMI and 25(OH)D serum levels (P = 0.037, r s = −0.266). In summary, this study suggested that 25(OH)D plays a protective role against MetS in RA patients. However, this cross-sectional study did not permit a power calculation on the causal relationship between Vit D and metabolic syndrome. On the other hand, Vit D has a negative correlation with BMI in these patients.
Url:
DOI: 10.1007/s10067-012-1995-3
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000A67
- to stream Istex, to step Curation: 000A67
- to stream Istex, to step Checkpoint: 000438
- to stream Main, to step Merge: 001430
- to stream Main, to step Curation: 001429
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Association between metabolic syndrome, BMI, and serum vitamin D concentrations in rheumatoid arthritis</title><author><name sortKey="Goshayeshi, Ladan" sort="Goshayeshi, Ladan" uniqKey="Goshayeshi L" first="Ladan" last="Goshayeshi">Ladan Goshayeshi</name></author><author><name sortKey="Saber, Hamidreza" sort="Saber, Hamidreza" uniqKey="Saber H" first="Hamidreza" last="Saber">Hamidreza Saber</name></author><author><name sortKey="Sahebari, Maryam" sort="Sahebari, Maryam" uniqKey="Sahebari M" first="Maryam" last="Sahebari">Maryam Sahebari</name></author><author><name sortKey="Rezaieyazdi, Zahra" sort="Rezaieyazdi, Zahra" uniqKey="Rezaieyazdi Z" first="Zahra" last="Rezaieyazdi">Zahra Rezaieyazdi</name></author><author><name sortKey="Rafatpanah, Houshang" sort="Rafatpanah, Houshang" uniqKey="Rafatpanah H" first="Houshang" last="Rafatpanah">Houshang Rafatpanah</name></author><author><name sortKey="Esmaily, Habibollah" sort="Esmaily, Habibollah" uniqKey="Esmaily H" first="Habibollah" last="Esmaily">Habibollah Esmaily</name></author><author><name sortKey="Goshayeshi, Lena" sort="Goshayeshi, Lena" uniqKey="Goshayeshi L" first="Lena" last="Goshayeshi">Lena Goshayeshi</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:5FCF668AB9D9A0FF9452E1CACA1A2ACCAA1B384B</idno><date when="2012" year="2012">2012</date><idno type="doi">10.1007/s10067-012-1995-3</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-15FZ0B1H-H/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000A67</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000A67</idno><idno type="wicri:Area/Istex/Curation">000A67</idno><idno type="wicri:Area/Istex/Checkpoint">000438</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000438</idno><idno type="wicri:doubleKey">0770-3198:2012:Goshayeshi L:association:between:metabolic</idno><idno type="wicri:Area/Main/Merge">001430</idno><idno type="wicri:Area/Main/Curation">001429</idno><idno type="wicri:Area/Main/Exploration">001429</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Association between metabolic syndrome, BMI, and serum vitamin D concentrations in rheumatoid arthritis</title><author><name sortKey="Goshayeshi, Ladan" sort="Goshayeshi, Ladan" uniqKey="Goshayeshi L" first="Ladan" last="Goshayeshi">Ladan Goshayeshi</name><affiliation wicri:level="1"><country xml:lang="fr">Iran</country><wicri:regionArea>School of Medicine, Mashhad University of Medical Sciences, Mashhad</wicri:regionArea><wicri:noRegion>Mashhad</wicri:noRegion></affiliation></author><author><name sortKey="Saber, Hamidreza" sort="Saber, Hamidreza" uniqKey="Saber H" first="Hamidreza" last="Saber">Hamidreza Saber</name><affiliation wicri:level="1"><country xml:lang="fr">Iran</country><wicri:regionArea>Rheumatic Diseases Research Center (RDRC), School of Medicine, Mashhad University of Medical Sciences, Mashhad</wicri:regionArea><wicri:noRegion>Mashhad</wicri:noRegion></affiliation></author><author><name sortKey="Sahebari, Maryam" sort="Sahebari, Maryam" uniqKey="Sahebari M" first="Maryam" last="Sahebari">Maryam Sahebari</name><affiliation wicri:level="1"><country xml:lang="fr">Iran</country><wicri:regionArea>Rheumatic Diseases Research Center (RDRC), School of Medicine, Mashhad University of Medical Sciences, Mashhad</wicri:regionArea><wicri:noRegion>Mashhad</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Iran</country><wicri:regionArea>Rheumatic Diseases Research Center (RDRC), Ghaem hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad</wicri:regionArea><wicri:noRegion>Mashhad</wicri:noRegion></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Iran</country></affiliation></author><author><name sortKey="Rezaieyazdi, Zahra" sort="Rezaieyazdi, Zahra" uniqKey="Rezaieyazdi Z" first="Zahra" last="Rezaieyazdi">Zahra Rezaieyazdi</name><affiliation wicri:level="1"><country xml:lang="fr">Iran</country><wicri:regionArea>Rheumatic Diseases Research Center (RDRC), School of Medicine, Mashhad University of Medical Sciences, Mashhad</wicri:regionArea><wicri:noRegion>Mashhad</wicri:noRegion></affiliation></author><author><name sortKey="Rafatpanah, Houshang" sort="Rafatpanah, Houshang" uniqKey="Rafatpanah H" first="Houshang" last="Rafatpanah">Houshang Rafatpanah</name><affiliation wicri:level="1"><country xml:lang="fr">Iran</country><wicri:regionArea>Immunology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad</wicri:regionArea><wicri:noRegion>Mashhad</wicri:noRegion></affiliation></author><author><name sortKey="Esmaily, Habibollah" sort="Esmaily, Habibollah" uniqKey="Esmaily H" first="Habibollah" last="Esmaily">Habibollah Esmaily</name><affiliation wicri:level="1"><country xml:lang="fr">Iran</country><wicri:regionArea>Rheumatic Diseases Research Center (RDRC), School of Medicine, Mashhad University of Medical Sciences, Mashhad</wicri:regionArea><wicri:noRegion>Mashhad</wicri:noRegion></affiliation></author><author><name sortKey="Goshayeshi, Lena" sort="Goshayeshi, Lena" uniqKey="Goshayeshi L" first="Lena" last="Goshayeshi">Lena Goshayeshi</name><affiliation wicri:level="1"><country xml:lang="fr">Iran</country><wicri:regionArea>Microbiology and Virology Research Center, Avesina Research Institute, School of Medicine, Mashhad University of Medical Sciences, Mashhad</wicri:regionArea><wicri:noRegion>Mashhad</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Clinical Rheumatology</title><title level="j" type="sub">Journal of the International League of Associations for Rheumatology</title><title level="j" type="abbrev">Clin Rheumatol</title><idno type="ISSN">0770-3198</idno><idno type="eISSN">1434-9949</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>London</pubPlace><date type="published" when="2012-08-01">2012-08-01</date><biblScope unit="volume">31</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="1197">1197</biblScope><biblScope unit="page" to="1203">1203</biblScope></imprint><idno type="ISSN">0770-3198</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0770-3198</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>BMI</term><term>Body mass index</term><term>Metabolic syndrome</term><term>Rheumatoid arthritis</term><term>Vitamin D</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Rheumatoid arthritis (RA) is the most common autoimmune arthritis. The impact of chronic inflammation on atherosclerosis and insulin resistance has been observed in several autoimmune diseases. On the other hand, metabolic syndrome (MetS); a cluster of traditional risk factors for atherosclerosis and diabetes seems to be prevalent in RA patients. It is reasonable to think that protective factors against inflammation can protect patients against atherosclerosis and diabetes, too. Vitamin D (Vit D), a novel immunomodulator, is recently considered to play a protective role against cardiovascular diseases, insulin resistance, and obesity. This cross-sectional study was designed to evaluate the impact of serum Vit D on MetS and body mass index (BMI). One hundred twenty RA patients were enrolled. MetS was assessed according to Adult Treatment Panel III criteria. All patients with known confounders influencing Vit D serum levels were excluded. Serum value of 25-hydroxyvitamin D (25(OH)D) was measured using a commercial ELISA kit. Data were analyzed by SPSS software. A logistic regression analysis stated that prednisolone dosage [p = 0.028, β = 0.177, odds ratio (OR) = 1.194, confidence interval (CI, 1.09–1.32)], age [p = 0.002, β = 0.146, OR = 1.57, CI (1.05–1.27)] and Vit D serum levels [p = 0.049, β = −3.766, OR = 0.023, CI (0.001–0.978)] are all significant predictors of MetS occurrence in RA patients. It was shown that 25(OH)D is a protective factor against MetS. It was also shown that there is a negative correlation between BMI and 25(OH)D serum levels (P = 0.037, r s = −0.266). In summary, this study suggested that 25(OH)D plays a protective role against MetS in RA patients. However, this cross-sectional study did not permit a power calculation on the causal relationship between Vit D and metabolic syndrome. On the other hand, Vit D has a negative correlation with BMI in these patients.</div></front></TEI><affiliations><list><country><li>Iran</li></country></list><tree><country name="Iran"><noRegion><name sortKey="Goshayeshi, Ladan" sort="Goshayeshi, Ladan" uniqKey="Goshayeshi L" first="Ladan" last="Goshayeshi">Ladan Goshayeshi</name></noRegion><name sortKey="Esmaily, Habibollah" sort="Esmaily, Habibollah" uniqKey="Esmaily H" first="Habibollah" last="Esmaily">Habibollah Esmaily</name><name sortKey="Goshayeshi, Lena" sort="Goshayeshi, Lena" uniqKey="Goshayeshi L" first="Lena" last="Goshayeshi">Lena Goshayeshi</name><name sortKey="Rafatpanah, Houshang" sort="Rafatpanah, Houshang" uniqKey="Rafatpanah H" first="Houshang" last="Rafatpanah">Houshang Rafatpanah</name><name sortKey="Rezaieyazdi, Zahra" sort="Rezaieyazdi, Zahra" uniqKey="Rezaieyazdi Z" first="Zahra" last="Rezaieyazdi">Zahra Rezaieyazdi</name><name sortKey="Saber, Hamidreza" sort="Saber, Hamidreza" uniqKey="Saber H" first="Hamidreza" last="Saber">Hamidreza Saber</name><name sortKey="Sahebari, Maryam" sort="Sahebari, Maryam" uniqKey="Sahebari M" first="Maryam" last="Sahebari">Maryam Sahebari</name><name sortKey="Sahebari, Maryam" sort="Sahebari, Maryam" uniqKey="Sahebari M" first="Maryam" last="Sahebari">Maryam Sahebari</name><name sortKey="Sahebari, Maryam" sort="Sahebari, Maryam" uniqKey="Sahebari M" first="Maryam" last="Sahebari">Maryam Sahebari</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001429 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001429 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:5FCF668AB9D9A0FF9452E1CACA1A2ACCAA1B384B
|texte= Association between metabolic syndrome, BMI, and serum vitamin D concentrations in rheumatoid arthritis
}}
| This area was generated with Dilib version V0.6.33. |  |